Why Milestone Pharma Stock Is Taking A Dive Today

• Milestone Pharmaceuticals stock is taking a hit today. Why is MIST stock falling?European Decision Timeline PushedIn January, the European Medicines Agency accepted the marketing application for etripamil in paroxysmal supraventricular tachycardia (PSVT), supported by the same global data package used for FDA approval in December 2025.PSVT is a type of arrhythmia (irregular heartbeat) characterized by sudden, sporadic bursts of a rapid, regular heart rate (120–230 bpm) that start and stop abruptly.The co ...